Lipoproteins, vascular-related genetic factors, and human longevity

Rejuvenation Research

Volumn 10, Issue 4, 2007, Pages 441-458

  Panza, Francesco ^a   D'Introno, Alessia ^a   Capurso, Cristiano ^b   Colacicco, Anna Maria ^a   Seripa, Davide ^c   Pilotto, Alberto ^c   Santamato, Andrea ^b   Capurso, Antonio ^a   Solfrizzi, Vincenzo ^a  

^a UNIVERSITY OF BARI   (Italy)

^b UNIVERSITY OF FOGGIA   (Italy)

^c CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; APOLIPOPROTEIN E2; APOLIPOPROTEIN E4; DIPEPTIDYL CARBOXYPEPTIDASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN; LIPOPROTEIN A;

AGING; ALZHEIMER DISEASE; APOE GENE; GENE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HEREDITY; HUMAN; LIFESPAN; LIPOPROTEIN METABOLISM; LONGEVITY; PRIORITY JOURNAL; REVIEW; VASCULAR DISEASE;

ALZHEIMER DISEASE; APOLIPOPROTEINS E; CARDIOVASCULAR DISEASES; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CORONARY ARTERY DISEASE; HUMANS; LIPOPROTEIN(A); LIPOPROTEINS; LONGEVITY; PARTICLE SIZE; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC;

EID: 37549017094     PISSN: 15491684     EISSN: None     Source Type: Journal    
DOI: 10.1089/rej.2007.0537     Document Type: Review

References (108)

1. Schachter F, Faure-Delanef L, Guenot F, Rouger H, Froguel P, Lesueur-Ginot L, Cohen D. Genetic associations with human longevity at the APOE and ACE loci. Nat Genet 1994;6:29-32.
2. Louhija J, Miettinen HE, Kontula K, Tikkanen MJ, Miettinen TA, Tilvis RS. Aging and genetic variation of plasma apolipoproteins. Relative loss of the apolipoprotein E4 phenotype in centenarians. Arterioscl Thromb 1994;14:1084-1089.
3. Panza F, Solfrizzi V, Torres F, Mastroianni F, Del Parigi A, Colacicco AM, Basile AM, Capurso C, Noya R, Capurso A. Decreased frequency of apolipoprotein E ε4 allele from Northern to Southern Europe in Alzheimer's disease patients and centenarians. Neurosci Lett 1999;277:53-56.
4. Saunders AM, Strittmatter WJ, Schmechel D, St. George-Hyslop PH, Pericak-Vance MA, Joo SH, Rosi BL, Gusella JF, Crapper-MacLachlan DR, Alberts MJ, Hulette C, Crain B, Goldgaber D, Roses AD. Association of apolipoprotein E allele ε4 with late-onset familial and sporadic Alzheimer's disease. Neurology 1993;43:1467-1472.
5. Eichner JE, Kuller LH, Orchard TJ, Grandits GA, McCallum LM, Ferrell RE, Neaton JD. Relation of apolipoprotein E phenotype to myocardial infarction and mortality from coronary artery disease. Am J Cardiol 1993;71:160-165.
6. Cambien F, Poirier O, Lecerf L, Evans AE, Cambou JP, Arveiller D, Luc G, Bard JM, Bara L, Ricard S, Tiret L, Amouyel P, Alhenc-Gelas F, Soubrier F. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 1992;359:641-644.
7. Kehoe PG, Russ C, McIlory S, Williams H, Holmans P, Holmes C, Lio-litsa D, Vahidassr D, Powell J, McGleenon B, Liddell M, Plomin R, Dynan K, Williams N, Neal J, Cairns NJ, Wilcock G, Passmore P, Lovestone S, Williams J, Owen MJ. Variation in DCP1, encoding ACE, is associated with susceptibility to Alzheimer disease. Nat Genet 1999;21:71-72.
8. Bladbjerg EM, Andersen-Ranberg K, De Maat MP, Kristensen SR, Jeune B, Gram J, Jespersen J. Longevity is independent of common variations in genes associated with cardiovascular risk. Thromb Haemost 1999;82:1100-1105.
9. Blanchè H, Cabanne L, Sahbatou M, Thomas G. A study of French centenarians: are ACE and APOE associated with longevity? CR Acad Sci III 2001;324: 129-135.
10. Choi YH, Kim JH, Kim DK, Kim JW, Kim DK, Lee MS, Kim CH, Park SC. Distributions of ACE and APOE polymorphisms and their relations with dementia status in Korean centenarians. J Gerontol A Biol Sci Med Sci 2003;58A:M227-M231.
11. Panza F, Solfrizzi V, D'Introno A, Colacicco AM, Capurso C, Capurso A, Kehoe PG, Capurso A. Angiotensin I converting enzyme (ACE1) gene polymorphism in centenarians: different allele frequencies between the North and South of Europe. Exp Gerontol 2003;38:1015-1020.
12. Panza F, D'Introno A, Colacicco AM, Capurso C, Capurso S, Kehoe PG, Capurso A, Solfrizzi V. Vascular genetic factors and human longevity. Mech Ageing Dev 2004;125:169-178.
13. Zenker G, Koltringer P, Bone G, Niederkorn K, Pfeiffer K, Jurgens G. Lipoprotein(a) as a strong indicator for cerebrovascular disease. Stroke 1986;17:942-945.
14. Danesh J, Collins R, Peto R. Lipoprotein(a) and coronary heart disease. Meta-analysis of prospective studies. Circulation 2000;102:1082-1085.
15. Couderc R, Mahieux F, Bailleul S, Fenelon G, Mary R, Fermanian J. Prevalence of apolipoprotein E phenotypes in ischemic cerebro-vascular disease. A case-control study. Stroke 1993;24:661-664.
16. Siest G, Pillot T, Regis-Bailly A, Leininger-Muller B, Steinmetz J, Galteau MM, Visvikis S. Apolipoprotein E: an important gene and protein to follow in laboratory medicine. Clin Chem 1995;41:1068-1086.
17. Davignon J, Gregg RE, Sing CF. Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis 1988;8:1-21.
18. Davignon J, Bouthillier D, Nestruck AC, Sing CF. Apolipoprotein E polymorphism and atherosclerosis: insight from a study in octagenarians. Trans Am Clin Climatol Assoc 1987;99:100-110.
19. Kervinen K, Savolainen MJ, Salokannel J, Hynninen A, Heikkinen J, Ehnholm C, Koistinen MJ, Kesaniemi YA. Apolipoprotein E and B polymorphisms ε longevity factors assessed in nonagenarians. Atherosclerosis 1994;105:89-95.
20. Rea IM, Mc Dowell I, McMaster D, Smye M, Stout R, Evans A; MONICA group (Belfast). Monitoring of Cardiovascular trends study group. Apolipoprotein E alleles in nonagenarian subjects in the Belfast Elderly Longitudinal Free-living Ageing Study (BELFAST). Mech Ageing Dev 2001;122:1367-1372.
21. Asada T, Yamagata Z, Kinoshita T, Kinoshita A, Kariya T, Asaka A, Kakuma T. Prevalence of dementia and distribution of ApoE alleles in Japanese centenarians: an almost-complete survey in Yamanashi Prefecture, Japan. J Am Geriatr Soc 1996;44:151-155.
22. Asada T, Kariya T, Yamagata Z, Kinoshita T, Asaka A. Apolipoprotein E allele in centenarians. Neurology 1996;46:1484.
23. Yamagata Z, Asada T, Kinoshita A, Zhang Y, Asaka A. Distribution of apolipoprotein E gene polymorphisms in Japanese patients with Alzheimer's disease and in Japanese centenarians. Hum Hered 1997;47:22-26.
24. Jian-Gang Z, Yong-Xing M, Chuan-Fu W, Pei-Fang L, Song-Bai Z, Nui-Fan G, Guo-Yin F, Lin H. Apolipoprotein E and longevity among Han Chinese population. Mech Ageing Dev 1998;104:159-167.
25. Rontu R, Ojala P, Hervonen A, Goebeler S, Karhunen PJ, Nikkila M, Kunnas T, Jylha M, Eklund C, Hurme M, Lehtimaki T. Apolipoprotein E genotype is related to plasma levels of C-reactive protein and lipids and to longevity in nonagenarians. Clin Endocrinol 2006;64:265-270.
26. Seripa D, Franceschi M, Matera MG, Panza F, Kehoe PG, Gravina C, Orsitto G, Solfrizzi V, Di Minno G, Dalla Piccola B, Pilotto A. Sex differences in the association of apolipoprotein E and angiotensin-converting enzyme gene polymorphisms with healthy aging and longevity: a population-based study from Southern Italy. J Gerontol A Biol Sci Med Sci 2006; 61:918-923.
27. Ewbank DC. Mortality differences by APOE genotype estimated from demographic synthesis. Genet Epidemiol 2002;22:146-155.
28. Gerdes LU, Jeune B, Ranberg KA, Nybo H, Vaupel JW. Estimation of apolipoprotein E genotype-specific relative mortality risks from the distribution of genotypes in centenarians and middle-aged men: apolipoprotein E gene is a "frailty gene," not a "longevity gene." Genet Epidemiol 2000;19:202-210.
29. Lewis SJ, Brunner EJ. Methodological problems in genetic association studies of longevity - the apolipoprotein E gene as an example. Int J Epidemiol 2004;33:962-970.
30. Bader G, Zuliani G, Kostner GM, Fellin R. Apolipoprotein E polymorphism is not associated with longevity or disability in a sample of Italian octoand nonagenarians. Gerontology 1998;44:293-299.
31. Forero DA, Pinzon J, Arboleda GH, Yunis JJ, Alvarez C, Catano N, Arboleda H. Analysis of common polymorphisms in angiotensin-converting enzyme and apolipoprotein e genes and human longevity in Colombia. Arch Med Res 2006;37:890-894.
32. Stessman J, Maaravi Y, Hammerman-Rozenberg R, Cohen A, Nemanov L, Gritsenko I, Gruberman N, Ebstein RP. Candidate genes associated with ageing and life expectancy in the Jerusalem longitudinal study. Mech Ageing Dev 2005;126:333-339.
33. Frisoni GB, Louhija J, Geroldi C, Trabucchi M. Longevity and the epsilon2 allele of apolipoprotein E: the Finnish Centenarians Study. J Gerontol A Biol Sci Med Sci 2001;56A:M75-M78.
34. Louhija J, Viitanen M, Aguero-Torres H, Tilvis R. Survival in Finnish centenarians in relation to apolipoprotein E polymorphism. J Am Geriatr Soc 2001;49:1007-1008.
35. Bathum L, Christiansen MSC, Bernard J, Vaupel J, McGue M, Christensen K. Apolipoprotein E genotypes: relationship to cognitive functioning, cognitive decline, and survival in nonagenarians. J Am Geriatr Soc 2006;54:654-658.
36. Formiga F, Alia P, Navarro MA, Pujol R. Apolipoprotein e genotypes in nonagenarians. J Am Geriatr Soc 2006;54:1471-1473.
37. World Population Prospects: The 2000 Revision, Vol. I, Comprehensive Tables. New York: United Nations Publications, 2001.
38. Franceschi C, Valensin S, Bonafe M, Paolisso G, Yashin AI, Monti D, De Benedictis G. The network and the remodeling theories of aging: historical background and new perspectives. Exp Gerontol 2000;35:879-896.
39. Tan Q, Kruse TA, Christensen K. Design and analysis in genetic studies of human ageing and longevity. Ageing Res Rev 2006;5:371-387.
40. Perls T, Terry D. Genetics of exceptional longevity. Exp Gerontol 2003;38:725-730.
41. Tilvis RS, Strandberg TE, Juva K. Apolipoprotein E phenotypes, dementia and mortality in a prospective population sample. J Am Geriatr Soc 1998;46: 712-715.
42. Slooter AJC. Apolipoprotein E and longevity: the Rotterdam study. J Am Geriatr Soc 2001;49:1258-1259.
43. Corder EH, Lannfelt L, Viitanen M, Corder LS, Manton KG, Winblad B, Basun H. Apolipoprotein E genotype determines survival in the oldest old (85 years or older) who have good cognition. Arch Neurol 1996;53:418-422.
44. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990;86:1343-1346.
45. Hu J, Igarashi A, Kamata M, Nakagawa H. Angiotensin-converting enzyme degrades Alzheimer amyloid beta-peptide (A beta), retards A beta aggregation, deposition, fibril formation, and inhibits cytotoxicity. J Biol Chem 2001;276:47863-47868.
46. Costerousse O, Jaspard E, Wei L, Corvol P, Alhenc-Gelas F. The angiotensin I-converting enzyme (kininase II): molecular organization and regulation of its expression in humans. J Cardiovasc Pharmacol 1992;20(Suppl 9):S10-S15.
47. Eisenlohr LC, Bacik I, Bennink JR, Bernstein K, Yewdell JW. Expression of a membrane protease enhances presentation of endogenous antigens to MHC class I-restricted T lymphocytes. Cell 1992;71:963-972.
48. Lehmann DJ, Cortina-Borja M, Warden DR, Smith AD, Sleegers K, Prince JA, van Duijn CM, Kehoe PG. Large meta-analysis establishes the ACE insertion-deletion polymorphism as a marker of Alzheimer's disease. Am J Epidemiol 2005;162:305-317.
49. Rahmutula D, Nakayama T, Izumi Y, Ozawa Y, Shimabukuro H, Kawamura H, Zhen-Wang S, Xiong-Wang J, Aisa M, Run-Yang C, Mahmut M, Mahsut R, Hen-Chen Z. Angiotensin-converting enzyme gene and longevity in the Xin Jiang Uighur autonomous region of China: an association study. J Gerontol A Biol Sci Med Sci 2002;57:M57-60.
50. Da Cruz IB, Oliveira G, Taufer M, Leal NF, Schwanke CH, Glock L, Moriguchi Y, Moriguchi EH. Angiotensin I-converting enzyme gene polymorphism in two ethnic groups living in Brazil's southern region: association with age. J Gerontol A Biol Sci Med Sci 2003;58:M851-816.
51. Agerholm-Larsen B, Nordestgaard BG, Steffensen R, Sorensen TI, Jensen G, Tybjaerg-Hansen A. ACE gene polymorphism: ischemic heart disease and longevity in 10,150 individuals. A case-referent and retrospective cohort study based on the Copenhagen City Heart Study. Circulation 1997;95:2358-2367.
52. Kritchevsky SB, Nicklas BJ, Visser M, Simonsick EM, Newman AB, Harris TB, Lange EM, Penninx BW, Goodpaster BH, Satterfield S, Colbert LH, Rubin M, Pahor SM. Angiotensin-converting enzyme insertion/deletion genotype, exercise, and physical decline. J Am Med Assoc 2005;294:691-698.
53. Galinsky D, Tysoe C, Brayne CE, Easton DF, Huppert FA, Dening TR, Paykel ES, Rubinsztein DC. Analysis of the apo E/apo C-I, angiotensin converting enzyme and methylenetetrahydrofolate reductase genes as candidates affecting human longevity. Atherosclerosis 1997;129:177-183.
54. Nacmias B, Bagnoli S, Tedde A, Cellini E, Bessi V, Guarnieri B, Ortensi L, Piacentini S, Bracco L, Sorbi S. Angiotensin converting enzyme insertion/deletion polymorphism in sporadic and familial Alzheimer's disease and longevity. Arch Gerontol Geriatr 2006 Dec 18; [Epub ahead of print].
55. Paolisso G, Manzella D, Ferrara N, Gambardella A, Abete P, Tagliamonte MR, De Lucia D, Furgi G, Picone C, Gentile S, Rengo F, Varricchio M. ACE gene polymorphism and insulin action in older subjects and healthy centenarians. J Am Geriatr Soc 2001; 49:610-614.
56. Panza F, Solfrizzi V, D'Introno A, Colacicco AM, Capurso C, Kehoe PG, Capurso A. Shifts in angiotensin I converting enzyme insertion allele frequency across Europe: implications for Alzheimer's disease risk. J Neurol Neurosurg Psychiatry 2003;74;1159-1161.
57. Schatz IJ, Masaki K, Yano K, Chen R, Rodriguez BL, Curb JD. Cholesterol and all-cause mortality in elderly people from the Honolulu Heart Program: a cohort study. Lancet 2001;358:351-355.
58. Weverling-Rijnsburger AW, Blauw GJ, Lagaay AM, Knook DL, Meinders AE, Westendorp RG. Total cholesterol and risk of mortality in the oldest old. Lancet 1997;350:1119-1123.
59. Wilson PW, Anderson KM, Harris T, Kannel WB, Castelli WP. Determinants of change in total cholesterol and HDL-C with age: the Framingham Study. J Gerontol A Biol Sci Med Sci 1994;49:M252-M257.
60. U.S. Department of Health and Human Services (DHHS). National Center for Health Statistics: Third National Health and Nutrition Survey, 1988-1994, NHANES III Second Laboratory Data File (CD-ROM series 11, No. 2A). Hyattsville, MD: Centers for Disease Control and Prevention, 1998.
61. Ron D, Aviram M, Brook JG. High density lipoprotein in octage-narians. Biochem Med 1983;30:253-260.
62. Nikkila M, Heikkinen J. High-density lipoprotein cholesterol and long-evity. Age Ageing 1990;19:119-124.
63. Nikkila M, Heikkinen J. Serum cholesterol, highdensity lipoprotein cholesterol and five-year survival in elderly people. Age Ageing 1990;19:403-408.
64. Campbell AJ, Busby WJ, Robertson MC. Over 80 years and no evidence of coronary heart disease: characteristics of a survivor group. J Am Geriatr Soc 1993;41:1333-1338.
65. Ettinger WH Jr, Verdery RB, Wahl PW, Fried LP. High density lipoprotein cholesterol subfractions in older people. J Gerontol Med Sci 1994;49:M116-M122.
66. Barbagallo CM, Averna MR, Frada G, Chessari S, Mangiacavallo G, Notarbartolo A. Plasma lipid, apolipoprotein and Lp(a) levels in elderly normolipidemic women: relationships with coronary heart disease and longevity. Gerontology 1995;41: 260-266.
67. Barbagallo CM, Averna MR, Frada G, Noto D, Cavera G, Notarbartolo A. Lipoprotein profile and high-density lipoproteins: subfractions distribution in centenarians. Gerontology 1998;44:106-110.
68. Paolisso G, Gambardella A, Ammendola S, Tagliamonte MR, Rizzo MR, Capurso A, Varricchio M. Preserved antilipolytic insulin action is associated with a less atherogenic plasma lipid profile in healthy centenarians. J Am Geriatr Soc 1997;45:1504-1509.
69. Arai Y, Hirose N, Nakazawa S, Yamamura K, Shimizu K, Takayama M, Ebihara Y, Osono Y, Homma S. Lipoprotein metabolism in Japanese centenarians: effects of apolipoprotein E polymorphism and nutritional status. J Am Geriatr Soc 2001;49: 1434-1341.
70. Barzilai N, Gabriely I, Gabriely M, Iankowitz N, Sorkin JD. Offspring of centenarians have a favorable lipid profile. J Am Geriatr Soc 2001;49:76-79.
71. Barzilai N, Atzmon G, Schechter C, Schaefer EJ, Cupples AL, Lipton R, Cheng S, Shuldiner AR. Unique lipoprotein phenotype and genotype associated with exceptional longevity. JAMA 2003;290:2030-2040.
72. Atzmon G, Rincon M, Schechter CB, Shuldiner AR, Lipton RB, Bergman A, Barzilai N. Lipoprotein genotype and conserved pathway for exceptional longevity in humans. PLoS Biol. 2006;4:e113.
73. Barzilai N, Atzmon G, Derby CA, Bauman JM, Lipton RB. A genotype of exceptional longevity is associated with preservation of cognitive function. Neurology 2006;67:2170-2175.
74. Heijmans BT, Beekman M, Houwing-Duistermaat JJ, Cobain MR, Powell J, Blauw GJ, van der Ouderaa F, Westendorp RG, Slagboom PE. Lipoprotein particle profiles mark familial and sporadic human longevity. PLoS Med 2006;3:e495.
75. Baggio G, Donazzan S, Monti D, Mari D, Martini S, Gabelli C, Dalla Vestra M, Previato L, Guido M, Pigozzo S, Cortella I, Crepaldi G, Franceschi C. Lipoprotein(a) and lipoprotein profile in healthy centenarians: a reappraisal of vascular risk factors. FASEB J 1998;12:433-437.
76. Pepe G, Di Perna V, Resta F, Lovecchio M, Chimienti G, Colacicco AM, Capurso A. In search of a biological pattern for human longevity: impact of apo A-IV genetic polymorphism on lipoproteins and the hyper-Lp(a) in centenarians. Atherosclerosis 1998; 137:407-417.
77. Thillet J, Doucet C, Chapman J, Herbeth B, Cohen D, Faure-Delanef L. Elevated lipoprotein(a) levels and small apo(a) isoforms are compatible with longevity: evidence from a large population of French centenarians. Atherosclerosis 1998;136:389-394.
78. Matsubara M, Akita H, Shibuya H, Chiba H. Decreased longevity in Japanese men, associated with low-molecular-weight apolipoprotein(a) phenotypes. Ann Clin Biochem 2001;38(Pt. 2):120-123.
79. Akita H, Matsubara M, Shibuya H, Fuda H, Chiba H. Effect of ageing on plasma lipoprotein(a) levels. Ann Clin Biochem 2002;39(Pt 3):237-240.
80. Solfrizzi V, Panza F, Colacicco AM, Capurso C, D'Introno A, Torres F, Baldassarre G, Capurso A. Relation of lipoprotein(a) as coronary risk factor to type 2 diabetes mellitus and low-density lipoprotein chole-sterol in patients >65 years of age (The Italian Longitudinal Study on Aging). Am J Cardiol 2002; 89:825-829.
81. Eaton DL, Fless GM, Kohr WJ, McLean JW, Xu QT, Miller CG, Lawn RM, Scanu AM. Partial amino acids sequence of apolipoprotein(a) shows that it is homologous to plasminogen. Proc Natl Acad Sci USA 1987;84:3224-3228.
82. Boerwinkle E, Leffert CC, Lin J, Lackner C, Chiesa G, Hobbs HH. Apolipoprotein(a) gene accounts for greater than 90% of the variation in plasma lipoprotein(a) concentrations. J Clin Invest 1992;90:52-60.
83. Rhoads GG, Dahlen G, Berg K, Morton NE, Dannenberg AL. Lp(a) lipoprotein as a risk factor for myocardial infarction. J Am Med Assoc 1986;256: 2540-2544.
84. Simons L, Friedlander Y, Simons J, McCallum J. Lipoprotein(a) is not associated with coronary heart disease in the elderly: cross-sectional data from the Dubbo study. Atherosclerosis 1993;99:87-95.
85. Sunayama S, Daida H, Mokuno H, Miyano H, Yokoi H, Lee YJ, Sakurai H, Yamaguchi H. Lack of increased coronary atherosclerotic risk due to elevated lipoprotein(a) in women > or = 55 years of age. Circulation 1996;94:1263-1268.
86. Chapman MJ, Huby T, Nigon F, Thillet J. Lipoprotein(a): implication in atherothrombosis. Atherosclerosis 1994;110(suppl):S69-S75.
87. Urakami K, Wada-Isoe K, Wakutani Y, Ikeda K, Ji Y, Yamagata K, Kowa H, Okada A, Adachi Y, Nakashima K. Lipoprotein(a) phenotypes in patients with vascular dementia. Dement Geriatr Cogn Disord 2000;11:135-138.
88. Snowdon DA, Greiner LH, Mortimer JA, Riley KP, Greiner PA, Markesbery WR. Brain infarction and the clinical expression of Alzheimer disease. The Nun Study. J Am Med Assoc 1997;277:813-817.
89. Mooser V, Helbecque N, Miklossy J, Marcovina SM, Nicod P, Amouyel P. Interactions between apolipoprotein E and apolipoprotein(a) in patients with late-onset Alzheimer disease. Ann Intern Med 2000;132: 533-537.
90. Solfrizzi V, Panza F, D'Introno A, Colacicco AM, Capurso C, Basile AM, Capurso A. Lipoprotein(a), apolipoprotein E genotype, and risk of Alzheimer's disease. J Neurol Neurosurg Psychiatry 2002;72:732-736.
91. Jenner JL, Ordovas JM, Lamon-Fava S, Schaefer MM, Wilson PW, Castelli WP, Schaefer EJ. Effects of age, sex, and menopausal status on plasma lipoprotein(a) levels. The Framingham Offspring Study. Circulation 1993;87:1135-1141.
92. Soma MR, Osnago-Gadda I, Paoletti R, Fumagalli R, Morrisett JD, Meschia M, Crosignani P. The lowering of lipoprotein[a] induced by estrogen plus progesterone replacement therapy in postmenopausal women. Arch Intern Med 1993;153: 1462-1468.
93. Nago N, Kayaba K, Hiraoka J, Matsuo H, Goto T, Kario K, Tsutsumi A, Nakamura Y, Igarashi M. Lipoprotein(a) levels in the Japanese population: influence of age and sex, and relation to atherosclerotic risk factors. The Jichi Medical School Cohort Study. Am J Epidemiol 1995;141:815-821.
94. Smit M, de Knijff P, Rosseneu M, Bury J, Klasen E, Frants R, Havekes L. Apolipoprotein E polymorphism in The Netherlands and its effect on plasma lipid and apolipoprotein levels. Hum Genet 1988; 80:287-292.
95. Utermann G, Pruin N, Steinmetz A. Polymorphism of apolipoprotein E. III. Effect of a single polymorphic gene locus on plasma lipid levels in man. Clin Genet 1979;15:63-72.
96. Neale MC, de Knijff P, Havekes LM, Boomsma DI. ApoE polymorphism accounts for only part of the genetic variation in quantitative ApoE levels. Genet Epidemiol 2000;18:331-340.
97. Laws SM, Taddei K, Martins G, Paton A, Fisher C, Clarnette R, Hallmayer J, Brooks WS, Gandy SE, Martins RN. The -491AA polymorphism in the APOE gene is associated with increased plasma apoE levels in Alzheimer's disease. Neuroreport 1999;10:879-882.
98. Roks G, Cruts M, Houwing-Duistermaat JJ, Dermaut B, Serneels S, Havekes LM, Hofman A, Breteler MM, Van Broeckhoven C, van Duijn CM.Effect of the APOE-491A/T promoter polymorphism on apolipoprotein E levels and risk of Alzheimer disease: The Rotterdam Study. Am J Med Genet 2002;114:570-573.
99. Panza F, Solfrizzi V, Colacicco AM, Basile AM, D'Introno A, Capurso C, Sabba M, Capurso S, Capurso A. Apolipoprotein E (APOE) polymorphism influences serum APOE levels in Alzheimer's disease patients and centenarians. Neuroreport 2003;14:605-608.
100. Cohn JS, Tremblay M, Amiot M, Bouthillier D, Roy M, Genest J Jr, Davignon J. Plasma concentration of apolipoprotein E in intermediate-sized remnant-like lipoproteins in normolipidemic and hyperlipidemic subjects. Arterioscler Thromb Vasc Biol 1996;16:149-159.
101. Reilly SL, Ferrell RE, Kottke BA, Sing CF. The gender-specific apolipoprotein E genotype influence on the distribution of plasma lipids and apolipoproteins in the population of Rochester, Minnesota. II. Regression relationships with concomitants. Am J Hum Genet. 1992;51:1311-1324.
102. Gracia V, Fiol C, Hurtado I, Pinto X, Argimon JM, Castineiras MJ. An enzyme-linked immunosorbent assay method to measure hu-man apolipoprotein E levels using commercially available reagents: effect of apolipoprotein E polymorphism on serum apolipoprotein E concen-tration. Anal Biochem 1994; 223:212-217.
103. Bohnet K, Pillot T, Visvikis S, Sabolovic N, Siest G. l. Apolipoprotein (apo) E genotype and apoE concentration determine binding of normal very low density lipoproteins to HepG2 cell surface receptors. J Lipid Res 1996;37:1316-1324.
104. Mooijaart SP, Berbee JF, van Heemst D, Havekes LM, de Craen AJ, Slagboom PE, Rensen PC, Westendorp RG. ApoE plasma levels and risk of cardiovascular mortality in old age. PLoS Med 2006;3:e176.
105. Stannard AK, Riddell DR, Sacre SM, Tagalakis AD, Langer C, von Eckardstein A, Cullen P, Athanasopoulos T, Dickson G, Owen JS. Cellderived apolipoprotein E (ApoE) particles inhibit vascular cell adhesion molecule-1 (VCAM-1) expression in human endothelial cells. J Biol Chem 2001;276: 46011-46016.
106. Bertram L, McQueen MB, Mullin K, Blacker D, Tanzi RE. Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database. Nat Genet 2007;39:17-23.
107. Lee JH, Tang MX, Schupf N, Stern Y, Jacobs DM, Tycko B, Mayeux R. Mortality and apolipoprotein E in Hispanic, African-American, and Caucasian elders. Am J Med Genet 2001;103:121-127.
108. Frederiksen H, Gaist D, Bathum L, Andersen K, McGue M, Vaupel JW, Christensen K. Angiotensin I-converting enzyme (ACE) gene polymorphism in relation to physical performance, cognition and survival(a follow-up study of elderly Danish twins. Ann Epidemiol 2003;13:57-65.